NRC Health Incurs $9.4M Expense to Amend Executive Equity Awards and Cover Tax Liabilities

summarizeSummary

NRC Health will recognize a $9.4 million expense in Q2 2026, including $2.9 million in cash bonuses, to amend executive equity awards and cover related tax obligations for its CEO, COO, and Chief Corporate Development Officer.

check_boxKey Events

• Executive Equity Award Amendments

  The Compensation and Talent Committee amended previously granted equity awards for CEO Trent Green (500,000 shares), COO Helen Hrdy (100,000 shares), and Chief Corporate Development Officer Andrew Monich (100,000 shares).

• Repurchase Right Elimination

  The amendments eliminated a repurchase right that created tax uncertainty regarding the vesting of these shares, ensuring they are fully vested for tax purposes.

• Significant Financial Expense

  The company expects to incur approximately $9.4 million in expense during Q2 2026, comprising $6.5 million in non-cash accelerated equity compensation and $2.9 million in cash bonuses to cover executives' estimated tax liabilities.

• Impact on Q2 Earnings

  This expense will negatively impact the company's second-quarter earnings and effective tax rate, though the acceleration of expense eliminates its impact on future periods.

auto_awesomeAnalysis

NRC Health is taking a significant financial hit to correct a prior compensation structure for its top executives. The $9.4 million expense, with a notable cash component, will impact Q2 2026 earnings and effective tax rate. While the amendment aims to fully vest previously granted shares and align executive interests, the cost highlights a past oversight in award structuring. Investors should monitor the Q2 earnings report for the full impact of this expense.